
    
      A Phase 1, Single-center, Randomized, 2-Way Cross-over, Open-label Study to Evaluate the
      Effect of Oral Repeated Doses of AZD1722 on the Pharmacokinetics of Oral Cefadroxil in
      Healthy Volunteers
    
  